We read with interest the article by Ghebremariam et al 1 demonstrating that proton pump inhibitors (PPIs) reduce endogenous formation of nitric oxide (NO) and impair vascular reactivity.
Intriguingly, nitrate also interacts directly with the pathway studied by Ghebremariam et al, 1 as demonstrated by decreases in asymmetrical diemethylarginine levels in a rat model of chronic cardiovascular disease after treatment with dietary nitrate. 5 In addition, PPI-induced inhibition of NO synthase will lead to a decrease in circulating levels of nitrate and nitrite, thereby affecting also the nitrate-nitrite-NO pathway. In aggregate, PPIs may disturb vascular NO homeostasis in 2 interconnected ways, both of which may contribute to the association between PPIs and cardiovascular risk.
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